Skip to content


For Calliditas to strategically carry out the relevant sustainability efforts and the sustainability reporting that meets transparency and accuracy requirements, the Company must be well acquainted with its most important sustainability matters from an environmental, social and corporate perspective.

The assessment was performed in accordance with the increased EU requirements on sustainability reporting – the Corporate Sustainability Reporting Directive (CSRD) and the associated mandatory reporting standards, the European Sustainability Reporting Standards (ESRS). Calliditas will be subject to the new requirements in its reporting for the 2025 financial year.

Double Materiality Assessment

The first step was a double materiality assessment, producing a comprehensive list of potential sustainability matters evaluated based on their impact on people, the environment and Calliditas’ financial position.

The assessment was performed by external experts in consultation with senior executives at Calliditas with knowledge of the specific relevant matters. Outcomes were presented in a matrix and verified by a group with similar positions and knowledge in the various areas before being approved by the CEO.

The methodically-performed assessment revealed seven main sustainability impact areas, categorized by environmental, social or governmental impact.

These material sustainability matters will guide Calliditas’ strategic sustainability efforts and reporting going forward.



  • Climate change is an important issue, given its global scope and impact as an issue that affects everyone to some extent.
  • Circular economy and waste are relevant issues to Calliditas, since the demand on hygiene results in considerable volumes of waste.


  • The health and safety for our own workforce is an area in which the company has a material impact, as well as being one that Calliditas has a high degree of control over.
  • For Calliditas to have a positive impact on the health of patients, its products must be accessible to end users.
  • The safety and quality of the product is hugely important, both for patients’ health and for Calliditas’ credibility.


  • The industry in which Calliditas operates has historically been exposed to an increased risk of corruption and bribery. Calliditas takes this seriously, as it may potentially have a major impact.
  • The management of animal welfare is particularly important, given that Calliditas engages in animal testing.

IR Contact

Åsa web photo (1)

Åsa Hillsten

Head of IR and Sustainability